The aim of this study was to investigate the feasibility of AuNP-aided prostate cancer radiation therapy by quantifying radiosensitization of PSMA-targeted AuNPs under megavoltage radiation energy at clinically relevant depths. The gene discussed is FOLH1; the disease is prostate carcinoma.